OFLOXACIN OTIC

OFLOXACIN OTIC was reported 7080 times

OFLOXACIN OTIC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTERIOR SEGMENT ISCHAEMIA 6 0.3158
1 FIBRIN 9 0.2093
2 LARYNGEAL HAEMATOMA 11 0.1642
3 KERATITIS FUNGAL 30 0.1442
4 TYPE 2 LEPRA REACTION 25 0.1337
5 CONJUNCTIVAL BLEB 5 0.0926
6 PERSISTENT LEFT SUPERIOR VENA CAVA 7 0.0654
7 PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION 11 0.0611
8 CORNEAL INFILTRATES 17 0.0541
9 CORNEAL DEPOSITS 38 0.0511
10 DELUSION OF REFERENCE 7 0.0504
11 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 9 0.0495
12 ANTERIOR CHAMBER FIBRIN 5 0.0388
13 CORNEAL PERFORATION 24 0.0380
14 RENAL NECROSIS 8 0.0367
15 TOXIC ANTERIOR SEGMENT SYNDROME 37 0.0339
16 CORNEAL GRAFT REJECTION 7 0.0333
17 CORNEAL SCAR 16 0.0318
18 CORNEAL THINNING 8 0.0311
19 HYPOPYON 24 0.0290
20 BONE METABOLISM DISORDER 8 0.0266
21 RECTAL SPASM 6 0.0260
22 FACTOR V INHIBITION 5 0.0258
23 ANTERIOR CHAMBER FLARE 6 0.0258
24 ANTERIOR CHAMBER CELL 18 0.0252
25 PERIORBITAL PAIN 20 0.0236
26 EYE ABSCESS 7 0.0230
27 CORNEAL EPITHELIUM DEFECT 13 0.0224
28 ANTICOAGULATION DRUG LEVEL INCREASED 7 0.0218
29 CORNEAL EROSION 11 0.0204
30 PROSTATIC PAIN 8 0.0196
31 GINGIVAL ULCERATION 14 0.0186
32 CORNEAL TRANSPLANT 14 0.0179
33 CORNEAL OEDEMA 39 0.0174
34 PROTHROMBIN TIME RATIO DECREASED 10 0.0160
35 TENDON DISCOMFORT 12 0.0159
36 EYELID PAIN 32 0.0157
37 THERAPEUTIC PRODUCT CROSS-REACTIVITY 14 0.0157
38 LAGOPHTHALMOS 6 0.0147
39 TENDON PAIN 111 0.0146
40 OTITIS MEDIA CHRONIC 6 0.0143
41 LENTICULAR OPACITIES 6 0.0137
42 PELVIC HAEMATOMA 6 0.0136
43 ANTERIOR CHAMBER INFLAMMATION 8 0.0134
44 GENERALISED BULLOUS FIXED DRUG ERUPTION 5 0.0134
45 CHRONIC FATIGUE SYNDROME 18 0.0129
46 UPPER AIRWAY OBSTRUCTION 11 0.0124
47 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 40 0.0123
48 NON-CARDIOGENIC PULMONARY OEDEMA 13 0.0123
49 SUDDEN INFANT DEATH SYNDROME 6 0.0122
50 ENDOPHTHALMITIS 71 0.0118
51 CORNEAL OPACITY 16 0.0117
52 ULCERATIVE KERATITIS 32 0.0117
53 HYPHAEMA 6 0.0115
54 EYE ULCER 6 0.0104
55 RETINAL PIGMENT EPITHELIAL TEAR 7 0.0101
56 RETINAL VASCULITIS 12 0.0101
57 PROSTATITIS 30 0.0098
58 VASCULITIS NECROTISING 7 0.0098
59 LARYNGEAL DISORDER 7 0.0097
60 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 10 0.0094
61 TENDON DISORDER 61 0.0093
62 BLADDER IRRITATION 6 0.0093
63 VASCULAR PURPURA 13 0.0093
64 OTITIS EXTERNA 11 0.0090
65 MUCOSAL EROSION 8 0.0088
66 HYPERPARATHYROIDISM SECONDARY 22 0.0088
67 TENDONITIS 130 0.0084
68 VITREOUS OPACITIES 7 0.0083
69 CROSS SENSITIVITY REACTION 8 0.0082
70 CORNEAL DISORDER 18 0.0082
71 SMALL FIBRE NEUROPATHY 6 0.0081
72 PERIODONTAL DISEASE 11 0.0078
73 NEPHROGENIC ANAEMIA 36 0.0078
74 TYMPANIC MEMBRANE PERFORATION 13 0.0077
75 DIARRHOEA INFECTIOUS 6 0.0076
76 EXTENSOR PLANTAR RESPONSE 7 0.0076
77 CORNEAL ABRASION 10 0.0073
78 COARCTATION OF THE AORTA 7 0.0072
79 KERATITIS 22 0.0072
80 EYE ROLLING 5 0.0071
81 ACQUIRED HAEMOPHILIA 7 0.0070
82 RASH MORBILLIFORM 19 0.0068
83 MOTION SICKNESS 13 0.0067
84 CYTOLYTIC HEPATITIS 22 0.0066
85 ORCHITIS 7 0.0065
86 EYE PAIN 364 0.0064
87 EYELID IRRITATION 16 0.0064
88 OSTEITIS 16 0.0063
89 HYPERMETROPIA 6 0.0063
90 OTORRHOEA 11 0.0063
91 SCLERITIS 10 0.0062
92 RETINAL DEGENERATION 8 0.0062
93 ILLUSION 10 0.0060
94 VITRITIS 11 0.0059
95 INTRA-ABDOMINAL HAEMORRHAGE 14 0.0059
96 FIXED ERUPTION 10 0.0058
97 EYE INFLAMMATION 54 0.0057
98 ATROPHY 11 0.0056
99 VITREOUS HAEMORRHAGE 15 0.0054
100 IMMUNE RECONSTITUTION SYNDROME 7 0.0054
101 METAMORPHOPSIA 10 0.0054
102 TESTICULAR PAIN 17 0.0054
103 OCULAR DISCOMFORT 60 0.0053
104 SUPERINFECTION 8 0.0053
105 FOREIGN BODY SENSATION IN EYES 34 0.0053
106 DYSAESTHESIA 16 0.0052
107 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
108 TENDON INJURY 19 0.0051
109 PERIODONTITIS 11 0.0051
110 CUTANEOUS VASCULITIS 18 0.0049
111 PHOTOPHOBIA 92 0.0049
112 NECROTISING COLITIS 6 0.0047
113 DACRYOSTENOSIS ACQUIRED 6 0.0046
114 ASTIGMATISM 7 0.0046
115 HENOCH-SCHONLEIN PURPURA 10 0.0046
116 MULTIPLE-DRUG RESISTANCE 14 0.0045
117 SWELLING OF EYELID 28 0.0045
118 EAR HAEMORRHAGE 9 0.0044
119 OTOTOXICITY 8 0.0043
120 EPIDIDYMITIS 5 0.0043
121 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 10 0.0043
122 HYPERACUSIS 16 0.0043
123 MUSCLE CONTRACTIONS INVOLUNTARY 15 0.0043
124 TENDON RUPTURE 51 0.0041
125 IRIDOCYCLITIS 13 0.0041
126 BICYTOPENIA 8 0.0041
127 HYPERAEMIA 8 0.0041
128 HALLUCINATIONS, MIXED 17 0.0040
129 PERSECUTORY DELUSION 10 0.0040
130 TENOSYNOVITIS 11 0.0040
131 EYE INFECTION 45 0.0040
132 HEPATOSPLENOMEGALY 10 0.0039
133 PRODUCT PACKAGING DIFFICULT TO OPEN 10 0.0038
134 CARDIOACTIVE DRUG LEVEL INCREASED 5 0.0038
135 EYELID MARGIN CRUSTING 11 0.0038
136 PUSTULE 9 0.0038
137 WEIGHT BEARING DIFFICULTY 10 0.0037
138 RENAL TUBULAR ACIDOSIS 8 0.0037
139 OCULAR HYPERTENSION 7 0.0036
140 PSEUDOMEMBRANOUS COLITIS 8 0.0036
141 PYELONEPHRITIS ACUTE 7 0.0036
142 TOXIC SKIN ERUPTION 35 0.0035
143 EYE OPERATION 16 0.0035
144 PYELONEPHRITIS 30 0.0035
145 VITREOUS FLOATERS 34 0.0035
146 INTRAOCULAR PRESSURE INCREASED 44 0.0034
147 MACULAR OEDEMA 19 0.0034
148 GENITAL PAIN 5 0.0034
149 CONJUNCTIVITIS ALLERGIC 5 0.0034
150 EYE DISCHARGE 35 0.0034
151 CONJUNCTIVAL HYPERAEMIA 12 0.0034
152 LIVER TRANSPLANT REJECTION 6 0.0033
153 MUSCLE RUPTURE 13 0.0033
154 CARTILAGE INJURY 8 0.0032
155 BLEPHARITIS 13 0.0032
156 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 25 0.0032
157 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 16 0.0032
158 DERMATITIS EXFOLIATIVE 16 0.0032
159 CEREBELLAR SYNDROME 7 0.0032
160 WRONG DRUG ADMINISTERED 28 0.0031
161 RETINAL OEDEMA 6 0.0031
162 ECCHYMOSIS 21 0.0031
163 HEPATIC CYTOLYSIS 39 0.0031
164 JOINT NOISE 6 0.0031
165 NECROSIS 17 0.0031
166 PURPURA 27 0.0030
167 EYE IRRITATION 175 0.0030
168 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 6 0.0030
169 EYELID DISORDER 7 0.0030
170 FOOD INTOLERANCE 11 0.0030
171 ENTEROBACTER INFECTION 5 0.0030
172 CHOLESTASIS 57 0.0030
173 END STAGE RENAL DISEASE 53 0.0029
174 CONJUNCTIVAL HAEMORRHAGE 11 0.0029
175 ELECTRIC SHOCK SENSATION 8 0.0029
176 EAR SWELLING 6 0.0028
177 MUSCLE ATROPHY 35 0.0028
178 ESCHERICHIA SEPSIS 8 0.0028
179 LACRIMATION INCREASED 83 0.0027
180 ESSENTIAL HYPERTENSION 5 0.0027
181 RETINAL DISORDER 7 0.0027
182 AGRANULOCYTOSIS 50 0.0027
183 NEURALGIA 65 0.0027
184 MENINGITIS ASEPTIC 12 0.0027
185 HYPOPROTEINAEMIA 5 0.0026
186 HYPOREFLEXIA 5 0.0026
187 CONJUNCTIVITIS 48 0.0026
188 BILIRUBIN CONJUGATED INCREASED 6 0.0026
189 TYPE I HYPERSENSITIVITY 9 0.0026
190 PATHOGEN RESISTANCE 23 0.0025
191 IMMOBILE 11 0.0025
192 CHRONIC KIDNEY DISEASE 190 0.0025
193 DERMATITIS BULLOUS 18 0.0025
194 SKIN EROSION 8 0.0025
195 HAEMOLYTIC ANAEMIA 22 0.0025
196 SKIN HYPERPIGMENTATION 21 0.0024
197 RETINAL TEAR 6 0.0024
198 VASCULAR DEVICE INFECTION 11 0.0024
199 OTITIS MEDIA 8 0.0024
200 AORTIC DISSECTION 10 0.0024
201 ERYTHEMA OF EYELID 13 0.0024
202 NEGATIVE THOUGHTS 7 0.0024
203 STRABISMUS 7 0.0024
204 OCULAR HYPERAEMIA 113 0.0024
205 SLEEP TERROR 10 0.0024
206 DRUG RESISTANCE 61 0.0024
207 EXCORIATION 6 0.0024
208 HYPERTHERMIA 18 0.0024
209 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 12 0.0024
210 RASH MACULO-PAPULAR 52 0.0023
211 HORDEOLUM 10 0.0023
212 PERIORBITAL SWELLING 13 0.0023
213 EYE SWELLING 85 0.0023
214 STEVENS-JOHNSON SYNDROME 50 0.0022
215 AREFLEXIA 6 0.0022
216 HAEMORRHAGIC DIATHESIS 8 0.0022
217 RETINAL HAEMORRHAGE 16 0.0022
218 EOSINOPHILIA 39 0.0022
219 FEAR OF DEATH 5 0.0022
220 PANIC REACTION 16 0.0022
221 HEPATITIS ACUTE 14 0.0022
222 INTERNATIONAL NORMALISED RATIO INCREASED 61 0.0021
223 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 55 0.0021
224 DEAFNESS NEUROSENSORY 7 0.0021
225 BLINDNESS UNILATERAL 30 0.0021
226 HEPATOCELLULAR INJURY 30 0.0021
227 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
228 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
229 ENCEPHALOPATHY 51 0.0021
230 EAR INFECTION 55 0.0021
231 PHOTOPSIA 13 0.0021
232 DRUG DISPENSING ERROR 31 0.0020
233 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 5 0.0020
234 PATENT DUCTUS ARTERIOSUS 8 0.0020
235 OESOPHAGEAL CANDIDIASIS 8 0.0020
236 HEPATITIS CHOLESTATIC 12 0.0020
237 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
238 DISSEMINATED TUBERCULOSIS 5 0.0019
239 EAR DISCOMFORT 20 0.0019
240 LOCALISED OEDEMA 9 0.0019
241 CATARACT 114 0.0019
242 ABNORMAL LOSS OF WEIGHT 13 0.0019
243 HYPERSENSITIVITY VASCULITIS 5 0.0019
244 INFUSION SITE PRURITUS 6 0.0019
245 VISUAL ACUITY REDUCED 63 0.0019
246 BLADDER PAIN 6 0.0019
247 PULMONARY TUBERCULOSIS 8 0.0019
248 CATARACT OPERATION 11 0.0019
249 ASPHYXIA 15 0.0018
250 PRODUCT ADMINISTRATION ERROR 37 0.0018
251 TONGUE DISCOLOURATION 8 0.0018
252 CLONUS 5 0.0018
253 ANHEDONIA 48 0.0018
254 ORAL CANDIDIASIS 24 0.0018
255 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
256 TINNITUS 83 0.0018
257 INTRACRANIAL PRESSURE INCREASED 10 0.0018
258 POST-TRAUMATIC STRESS DISORDER 12 0.0018
259 PLANTAR FASCIITIS 6 0.0018
260 EAR PAIN 34 0.0017
261 HERPES VIRUS INFECTION 10 0.0017
262 HYPERREFLEXIA 6 0.0017
263 ESCHERICHIA INFECTION 14 0.0017
264 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
265 FACIAL PAIN 15 0.0017
266 PRODUCT DELIVERY MECHANISM ISSUE 9 0.0017
267 ATYPICAL PNEUMONIA 5 0.0017
268 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
269 FEBRILE BONE MARROW APLASIA 7 0.0016
270 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
271 JAW DISORDER 9 0.0016
272 HEPATITIS 42 0.0016
273 RETINAL DETACHMENT 15 0.0016
274 PARADOXICAL DRUG REACTION 6 0.0016
275 ABNORMAL SENSATION IN EYE 7 0.0016
276 CHRONIC SINUSITIS 6 0.0016
277 ACUTE KIDNEY INJURY 243 0.0016
278 PARANASAL SINUS DISCOMFORT 6 0.0016
279 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
280 CARDIAC VALVE DISEASE 9 0.0016
281 MYOSITIS 14 0.0016
282 LYMPHOPENIA 22 0.0016
283 RENAL FAILURE 206 0.0015
284 SKIN NECROSIS 8 0.0015
285 FACE OEDEMA 26 0.0015
286 HYPERTRIGLYCERIDAEMIA 9 0.0015
287 INFUSION SITE HAEMORRHAGE 5 0.0015
288 BK VIRUS INFECTION 5 0.0015
289 SKIN ABRASION 7 0.0015
290 SHOCK HAEMORRHAGIC 12 0.0015
291 HYDROCEPHALUS 8 0.0015
292 EYELID OEDEMA 17 0.0015
293 ARTHRITIS BACTERIAL 6 0.0015
294 HYPERURICAEMIA 6 0.0015
295 HEPATIC FIBROSIS 5 0.0015
296 ASTHENOPIA 8 0.0015
297 ENCEPHALITIS 10 0.0014
298 FORMICATION 10 0.0014
299 MYOCLONUS 17 0.0014
300 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
301 HYPOTONIA 14 0.0014
302 GLAUCOMA 27 0.0014
303 NEUROLOGICAL SYMPTOM 8 0.0014
304 HERPES SIMPLEX 9 0.0014
305 OCULAR ICTERUS 6 0.0014
306 TRANSPLANT REJECTION 11 0.0014
307 ASPERGILLUS INFECTION 9 0.0014
308 PARONYCHIA 6 0.0014
309 RHINITIS 11 0.0014
310 HAEMATOMA 35 0.0013
311 SKIN MASS 9 0.0013
312 PLEURISY 8 0.0013
313 RENAL FAILURE ACUTE 57 0.0013
314 PETECHIAE 14 0.0013
315 POLYNEUROPATHY 16 0.0013
316 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 10 0.0013
317 MULTI-ORGAN FAILURE 23 0.0013
318 MUSCLE TWITCHING 30 0.0013
319 PIGMENTATION DISORDER 8 0.0013
320 MUSCULOSKELETAL DISCOMFORT 22 0.0013
321 HYPERKERATOSIS 7 0.0013
322 DRY EYE 63 0.0013
323 RECALLED PRODUCT ADMINISTERED 12 0.0013
324 ECONOMIC PROBLEM 19 0.0013
325 KIDNEY TRANSPLANT REJECTION 6 0.0012
326 PRODUCT LEAKAGE 7 0.0012
327 CANDIDA INFECTION 21 0.0012
328 MUSCLE DISORDER 10 0.0012
329 PANIC ATTACK 45 0.0012
330 GASTROENTERITIS 18 0.0012
331 HEPATOMEGALY 12 0.0012
332 TOXIC ENCEPHALOPATHY 6 0.0012
333 STAPHYLOCOCCAL INFECTION 39 0.0012
334 BACTERAEMIA 14 0.0012
335 PETIT MAL EPILEPSY 6 0.0012
336 CACHEXIA 6 0.0012
337 MALNUTRITION 13 0.0012
338 ANURIA 10 0.0012
339 VISION BLURRED 159 0.0012
340 MULTIPLE ALLERGIES 9 0.0011
341 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
342 EXTRASYSTOLES 8 0.0011
343 PARTIAL SEIZURES 6 0.0011
344 DIVERTICULUM INTESTINAL 5 0.0011
345 PAPULE 8 0.0011
346 HALLUCINATION, AUDITORY 18 0.0011
347 GENERALISED OEDEMA 14 0.0011
348 BLINDNESS 46 0.0011
349 DRUG ERUPTION 20 0.0011
350 SEPTIC SHOCK 49 0.0011
351 EYE HAEMORRHAGE 15 0.0011
352 VISUAL FIELD DEFECT 8 0.0011
353 ACUTE HEPATIC FAILURE 15 0.0011
354 VISUAL IMPAIRMENT 136 0.0011
355 MEDICATION ERROR 61 0.0011
356 IMMUNE THROMBOCYTOPENIA 5 0.0011
357 EAR DISORDER 5 0.0011
358 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
359 BLINDNESS TRANSIENT 8 0.0011
360 NERVE INJURY 12 0.0011
361 STREPTOCOCCAL INFECTION 6 0.0011
362 IMPAIRED WORK ABILITY 23 0.0011
363 ORAL HERPES 21 0.0011
364 ATRIAL SEPTAL DEFECT 9 0.0011
365 ACUTE PULMONARY OEDEMA 6 0.0011
366 STATUS EPILEPTICUS 12 0.0011
367 NEUROPATHY PERIPHERAL 101 0.0011
368 PAROSMIA 8 0.0011
369 BLOOD URINE PRESENT 20 0.0011
370 PRODUCT CONTAINER ISSUE 9 0.0010
371 LIPASE INCREASED 8 0.0010
372 HYPOVOLAEMIC SHOCK 5 0.0010
373 ENTEROCOLITIS 6 0.0010
374 PANCYTOPENIA 58 0.0010
375 SOCIAL AVOIDANT BEHAVIOUR 6 0.0010
376 TRANSAMINASES INCREASED 23 0.0010
377 HYPOALBUMINAEMIA 8 0.0010
378 APATHY 15 0.0010
379 NERVOUS SYSTEM DISORDER 32 0.0010
380 GROIN PAIN 9 0.0010
381 TUMOUR LYSIS SYNDROME 9 0.0010
382 NASAL DISCOMFORT 8 0.0010
383 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
384 SLEEP APNOEA SYNDROME 19 0.0010
385 HAEMATURIA 34 0.0010
386 OPTIC NEURITIS 9 0.0010
387 SEASONAL ALLERGY 14 0.0010
388 ADRENAL INSUFFICIENCY 12 0.0010
389 DIVERTICULUM 7 0.0010
390 RASH PAPULAR 22 0.0010
391 MUSCLE INJURY 8 0.0010
392 DERMATITIS CONTACT 11 0.0010
393 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
394 UVEITIS 13 0.0010
395 INFUSION SITE SWELLING 6 0.0010
396 SKIN LESION 26 0.0009
397 ARTHROPOD BITE 7 0.0009
398 DRUG INTERACTION 149 0.0009
399 PSEUDOMONAS INFECTION 8 0.0009
400 INFUSION SITE PAIN 12 0.0009
401 CHEILITIS 5 0.0009
402 VITAMIN D DEFICIENCY 9 0.0009
403 EYE PRURITUS 31 0.0009
404 HYPOGAMMAGLOBULINAEMIA 6 0.0009
405 PHOTOSENSITIVITY REACTION 15 0.0009
406 DEAFNESS UNILATERAL 5 0.0009
407 FIBROMYALGIA 22 0.0009
408 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
409 THROMBOCYTOPENIA 101 0.0009
410 HALLUCINATION, VISUAL 19 0.0009
411 SALIVARY HYPERSECRETION 9 0.0009
412 BRAIN FOG 14 0.0009
413 PANCREATITIS ACUTE 20 0.0009
414 OSTEONECROSIS OF JAW 22 0.0009
415 PRODUCT USE COMPLAINT 14 0.0009
416 EYELID PTOSIS 9 0.0009
417 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
418 BLOOD ALBUMIN DECREASED 7 0.0009
419 EYE DISORDER 29 0.0009
420 DRUG TOXICITY 12 0.0009
421 RIB FRACTURE 18 0.0009
422 HYPERBILIRUBINAEMIA 9 0.0009
423 EXERCISE TOLERANCE DECREASED 5 0.0009
424 HYPERTRANSAMINASAEMIA 6 0.0009
425 POST PROCEDURAL INFECTION 7 0.0009
426 NEPHROPATHY 8 0.0009
427 JAUNDICE 23 0.0009
428 DRUG LEVEL INCREASED 14 0.0008
429 LEUKOPENIA 42 0.0008
430 GRAFT VERSUS HOST DISEASE 6 0.0008
431 RESPIRATORY DISTRESS 23 0.0008
432 CYANOSIS 13 0.0008
433 RASH PUSTULAR 6 0.0008
434 MYALGIA 140 0.0008
435 IMPAIRED HEALING 27 0.0008
436 INGUINAL HERNIA 5 0.0008
437 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
438 RENAL TUBULAR NECROSIS 8 0.0008
439 THROAT TIGHTNESS 22 0.0008
440 MUSCLE STRAIN 7 0.0008
441 BURNING SENSATION 56 0.0008
442 SPINAL OSTEOARTHRITIS 7 0.0008
443 JOINT INJURY 17 0.0008
444 EMPHYSEMA 8 0.0008
445 LYMPHADENOPATHY 28 0.0008
446 NECK PAIN 44 0.0008
447 ACIDOSIS 6 0.0008
448 PARAESTHESIA 123 0.0008
449 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
450 GASTROINTESTINAL INFECTION 7 0.0008
451 MYDRIASIS 10 0.0008
452 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
453 ANAL INCONTINENCE 7 0.0008
454 MADAROSIS 9 0.0008
455 DIALYSIS 11 0.0008
456 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
457 DELUSION 12 0.0008
458 PARAESTHESIA ORAL 11 0.0008
459 CONFUSIONAL STATE 123 0.0008
460 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
461 ANAEMIA 145 0.0008
462 ORAL PAIN 17 0.0008
463 GRAND MAL CONVULSION 7 0.0008
464 INCONTINENCE 8 0.0008
465 RENAL CYST 6 0.0008
466 VERTIGO 46 0.0008
467 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
468 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
469 HEPATIC ENCEPHALOPATHY 7 0.0007
470 URINARY INCONTINENCE 22 0.0007
471 PULMONARY MASS 11 0.0007
472 DECUBITUS ULCER 6 0.0007
473 MUSCULOSKELETAL DISORDER 14 0.0007
474 ALANINE AMINOTRANSFERASE INCREASED 45 0.0007
475 DIPLOPIA 19 0.0007
476 MUSCULAR WEAKNESS 83 0.0007
477 MANIA 12 0.0007
478 HYPERCHOLESTEROLAEMIA 7 0.0007
479 OSTEOPENIA 11 0.0007
480 ANGIOEDEMA 32 0.0007
481 DENTAL CARIES 8 0.0007
482 CYTOMEGALOVIRUS INFECTION 12 0.0007
483 SECRETION DISCHARGE 9 0.0007
484 PHARYNGEAL SWELLING 7 0.0007
485 RASH MACULAR 25 0.0007
486 SKIN INFECTION 8 0.0007
487 HYPERKALAEMIA 25 0.0007
488 SENSATION OF FOREIGN BODY 6 0.0007
489 ANXIETY 202 0.0007
490 LUNG INFECTION 11 0.0007
491 NEUTROPENIA 96 0.0007
492 PAIN IN JAW 20 0.0007
493 SINUS TACHYCARDIA 10 0.0007
494 SCAB 8 0.0007
495 DRUG-INDUCED LIVER INJURY 22 0.0007
496 ANAPHYLACTIC SHOCK 18 0.0007
497 INFLAMMATION 36 0.0007
498 BLOOD MAGNESIUM DECREASED 6 0.0007
499 CARDIO-RESPIRATORY ARREST 29 0.0007
500 ANOSMIA 10 0.0007
501 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
502 SENSORY DISTURBANCE 11 0.0007
503 PULMONARY CONGESTION 9 0.0007
504 HEAD DISCOMFORT 12 0.0007
505 ASPARTATE AMINOTRANSFERASE INCREASED 36 0.0007
506 PALPITATIONS 79 0.0007
507 LUNG DISORDER 33 0.0007
508 HYPERLIPIDAEMIA 8 0.0007
509 URINARY TRACT INFECTION 114 0.0007
510 RENAL PAIN 7 0.0007
511 FUNGAL INFECTION 22 0.0007
512 BURSITIS 8 0.0007
513 AORTIC ANEURYSM 5 0.0007
514 PNEUMONIA BACTERIAL 6 0.0007
515 AGITATION 48 0.0007
516 DEAFNESS 17 0.0006
517 HEPATIC STEATOSIS 12 0.0006
518 THERAPY INTERRUPTED 46 0.0006
519 EJECTION FRACTION DECREASED 10 0.0006
520 DIARRHOEA HAEMORRHAGIC 6 0.0006
521 THERAPY PARTIAL RESPONDER 10 0.0006
522 BONE MARROW FAILURE 13 0.0006
523 OSTEOARTHRITIS 27 0.0006
524 BLOOD BILIRUBIN INCREASED 17 0.0006
525 DEVICE USE ISSUE 11 0.0006
526 IMPAIRED QUALITY OF LIFE 9 0.0006
527 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 30 0.0006
528 HALLUCINATION 47 0.0006
529 SLEEP DISORDER 44 0.0006
530 BRONCHITIS 46 0.0006
531 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
532 MUSCLE TIGHTNESS 10 0.0006
533 GENERAL PHYSICAL HEALTH DETERIORATION 71 0.0006
534 PLATELET COUNT INCREASED 8 0.0006
535 DISTURBANCE IN ATTENTION 33 0.0006
536 HICCUPS 5 0.0006
537 HYPERAESTHESIA 5 0.0006
538 BEDRIDDEN 8 0.0006
539 GASTRITIS 16 0.0006
540 TACHYCARDIA 54 0.0006
541 COLITIS 23 0.0006
542 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
543 DISORIENTATION 24 0.0006
544 ARTHRALGIA 251 0.0006
545 ELECTROLYTE IMBALANCE 7 0.0006
546 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
547 APHASIA 18 0.0006
548 FULL BLOOD COUNT DECREASED 12 0.0006
549 INFUSION SITE ERYTHEMA 5 0.0006
550 HYPOTHERMIA 6 0.0006
551 PYREXIA 205 0.0006
552 HIP FRACTURE 19 0.0006
553 IMPAIRED GASTRIC EMPTYING 8 0.0006
554 MACULAR DEGENERATION 7 0.0006
555 RASH ERYTHEMATOUS 28 0.0006
556 SINUSITIS 60 0.0006
557 MUSCLE RIGIDITY 7 0.0006
558 INITIAL INSOMNIA 6 0.0006
559 DEVICE RELATED INFECTION 9 0.0006
560 TEMPERATURE INTOLERANCE 6 0.0006
561 GASTROINTESTINAL DISORDER 52 0.0006
562 POOR VENOUS ACCESS 6 0.0006
563 CONDITION AGGRAVATED 176 0.0006
564 GASTRIC ULCER 11 0.0006
565 NOCTURIA 7 0.0006
566 HYPOAESTHESIA 86 0.0006
567 COORDINATION ABNORMAL 8 0.0006
568 ACUTE RESPIRATORY FAILURE 11 0.0006
569 CYTOPENIA 7 0.0006
570 NEUROTOXICITY 10 0.0006
571 DEPRESSED MOOD 30 0.0006
572 IMMUNOSUPPRESSION 5 0.0006
573 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
574 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
575 SCIATICA 9 0.0006
576 PHARYNGITIS 7 0.0006
577 AGEUSIA 14 0.0006
578 GASTROOESOPHAGEAL REFLUX DISEASE 45 0.0006
579 PARALYSIS 8 0.0006
580 DERMATITIS ALLERGIC 7 0.0006
581 MYELODYSPLASTIC SYNDROME 8 0.0006
582 SKIN LACERATION 6 0.0006
583 PALLOR 15 0.0006
584 PNEUMONITIS 15 0.0006
585 ARRHYTHMIA 26 0.0005
586 DYSPHAGIA 52 0.0005
587 DELIRIUM 19 0.0005
588 GASTROINTESTINAL PAIN 6 0.0005
589 ROTATOR CUFF SYNDROME 7 0.0005
590 DEPRESSION 124 0.0005
591 ANOREXIA 7 0.0005
592 SKIN ULCER 14 0.0005
593 FOOT DEFORMITY 6 0.0005
594 INSOMNIA 144 0.0005
595 ARTHROPATHY 30 0.0005
596 INFECTION 78 0.0005
597 RENAL INJURY 16 0.0005
598 SEPSIS 60 0.0005
599 DEMENTIA 15 0.0005
600 NODULE 7 0.0005
601 ERYTHEMA MULTIFORME 5 0.0005
602 ARTHRITIS 42 0.0005
603 FLANK PAIN 5 0.0005
604 MENTAL DISORDER 23 0.0005
605 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
606 PRODUCT DOSE OMISSION ISSUE 155 0.0005
607 PROTEINURIA 10 0.0005
608 MUSCULOSKELETAL STIFFNESS 46 0.0005
609 DERMATITIS 11 0.0005
610 CONVULSION 30 0.0005
611 RENAL IMPAIRMENT 44 0.0005
612 ANGINA PECTORIS 15 0.0005
613 EPILEPSY 16 0.0005
614 CARDIAC FAILURE 42 0.0005
615 C-REACTIVE PROTEIN INCREASED 19 0.0005
616 SHOCK 12 0.0005
617 FEAR 14 0.0005
618 TREATMENT FAILURE 43 0.0005
619 MUSCULOSKELETAL CHEST PAIN 8 0.0005
620 HYPONATRAEMIA 29 0.0005
621 COGNITIVE DISORDER 24 0.0005
622 VIRAL INFECTION 17 0.0005
623 BONE DENSITY DECREASED 16 0.0005
624 HEPATIC FUNCTION ABNORMAL 19 0.0005
625 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
626 COMA 24 0.0005
627 EMOTIONAL DISTRESS 61 0.0005
628 CHOLECYSTITIS 6 0.0005
629 INCORRECT ROUTE OF DRUG ADMINISTRATION 18 0.0005
630 MASS 7 0.0005
631 CARPAL TUNNEL SYNDROME 7 0.0005
632 HYPOKALAEMIA 23 0.0005
633 OSTEOMYELITIS 9 0.0005
634 SKIN REACTION 7 0.0005
635 SPEECH DISORDER 26 0.0005
636 RHINORRHOEA 32 0.0005
637 LACTIC ACIDOSIS 16 0.0005
638 HEPATOTOXICITY 11 0.0005
639 RENAL DISORDER 23 0.0005
640 TREATMENT NONCOMPLIANCE 27 0.0005
641 PAIN IN EXTREMITY 145 0.0005
642 DRUG LEVEL DECREASED 5 0.0005
643 BRONCHOSPASM 7 0.0005
644 THERAPY NON-RESPONDER 22 0.0005
645 OSTEOPOROSIS 20 0.0005
646 HYPERCALCAEMIA 6 0.0005
647 HYPOKINESIA 7 0.0005
648 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
649 DYSSTASIA 14 0.0005
650 GAIT INABILITY 16 0.0005
651 LIMB INJURY 13 0.0005
652 PLEURAL EFFUSION 29 0.0005
653 PERICARDIAL EFFUSION 11 0.0005
654 MOUTH ULCERATION 10 0.0005
655 BACK PAIN 110 0.0005
656 SKIN HAEMORRHAGE 7 0.0005
657 HERPES ZOSTER 27 0.0005
658 SUICIDAL IDEATION 43 0.0005
659 BODY HEIGHT DECREASED 5 0.0005
660 SCAR 8 0.0005
661 PARANOIA 8 0.0005
662 DYSURIA 17 0.0005
663 THERAPEUTIC RESPONSE DECREASED 28 0.0005
664 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
665 HAEMORRHOIDS 9 0.0005
666 SURGERY 27 0.0005
667 PRODUCT DISPENSING ERROR 10 0.0005
668 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
669 INTENTIONAL DOSE OMISSION 13 0.0005
670 RHABDOMYOLYSIS 19 0.0005
671 DISABILITY 9 0.0005
672 EPISTAXIS 34 0.0005
673 SINUS DISORDER 9 0.0005
674 NO ADVERSE EVENT 82 0.0005
675 ANAPHYLACTIC REACTION 25 0.0005
676 LIMB DISCOMFORT 14 0.0005
677 PRESYNCOPE 11 0.0005
678 MUSCLE SPASMS 83 0.0005
679 TOOTH DISORDER 10 0.0004
680 ACUTE MYELOID LEUKAEMIA 7 0.0004
681 ISCHAEMIC STROKE 8 0.0004
682 SWOLLEN TONGUE 14 0.0004
683 HEADACHE 281 0.0004
684 LIVER INJURY 11 0.0004
685 SWELLING FACE 29 0.0004
686 BLISTER 25 0.0004
687 BLOOD CREATININE INCREASED 29 0.0004
688 SINUS CONGESTION 6 0.0004
689 EXTRAPYRAMIDAL DISORDER 11 0.0004
690 OEDEMA 24 0.0004
691 PRODUCTIVE COUGH 21 0.0004
692 CYSTITIS 14 0.0004
693 BONE DISORDER 8 0.0004
694 ABSCESS 7 0.0004
695 HYPOTHYROIDISM 14 0.0004
696 ERYTHEMA 90 0.0004
697 NEPHROLITHIASIS 20 0.0004
698 INTERSTITIAL LUNG DISEASE 21 0.0004
699 HYPOGLYCAEMIA 21 0.0004
700 HEPATIC FAILURE 13 0.0004
701 DYSGEUSIA 32 0.0004
702 URTICARIA 72 0.0004
703 TREMOR 71 0.0004
704 OXYGEN SATURATION DECREASED 24 0.0004
705 INTESTINAL OBSTRUCTION 16 0.0004
706 FOOT FRACTURE 8 0.0004
707 BLOOD IRON DECREASED 5 0.0004
708 ATAXIA 5 0.0004
709 MUSCULOSKELETAL PAIN 22 0.0004
710 FEMUR FRACTURE 13 0.0004
711 HYPOACUSIS 18 0.0004
712 BLOOD UREA INCREASED 7 0.0004
713 GAIT DISTURBANCE 80 0.0004
714 PAIN 256 0.0004
715 LOWER LIMB FRACTURE 8 0.0004
716 FLUID RETENTION 21 0.0004
717 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
718 PNEUMONIA 133 0.0004
719 OEDEMA PERIPHERAL 50 0.0004
720 RESTLESSNESS 15 0.0004
721 BONE PAIN 24 0.0004
722 MELAENA 9 0.0004
723 ILLNESS 42 0.0004
724 MEMORY IMPAIRMENT 56 0.0004
725 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
726 CARDIOMYOPATHY 6 0.0004
727 NIGHTMARE 14 0.0004
728 PULMONARY OEDEMA 18 0.0004
729 ECZEMA 21 0.0004
730 RESPIRATORY DISORDER 12 0.0004
731 ATRIAL FIBRILLATION 39 0.0004
732 PNEUMONIA ASPIRATION 10 0.0004
733 ABDOMINAL PAIN 93 0.0004
734 CYTOKINE RELEASE SYNDROME 8 0.0004
735 DYSARTHRIA 15 0.0004
736 PRODUCT DOSE OMISSION 26 0.0004
737 SEIZURE 46 0.0004
738 HYPOXIA 14 0.0004
739 MENTAL STATUS CHANGES 11 0.0004
740 BALANCE DISORDER 34 0.0004
741 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
742 FALL 130 0.0004
743 SKIN DISORDER 13 0.0004
744 RASH PRURITIC 21 0.0004
745 TOOTHACHE 7 0.0004
746 HIATUS HERNIA 5 0.0004
747 INFLUENZA 43 0.0004
748 RESPIRATORY TRACT INFECTION 10 0.0004
749 ACCIDENTAL OVERDOSE 14 0.0004
750 PRURITUS 147 0.0004
751 RASH 166 0.0004
752 IMMUNE SYSTEM DISORDER 5 0.0004
753 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
754 OROPHARYNGEAL PAIN 35 0.0004
755 PRODUCT PRESCRIBING ERROR 9 0.0004
756 HYPERSENSITIVITY 70 0.0004
757 BRADYCARDIA 20 0.0004
758 OBESITY 6 0.0004
759 EATING DISORDER 8 0.0004
760 METABOLIC ACIDOSIS 12 0.0004
761 NIGHT SWEATS 12 0.0004
762 DYSPNOEA EXERTIONAL 14 0.0004
763 PSORIATIC ARTHROPATHY 15 0.0004
764 BLOOD POTASSIUM INCREASED 6 0.0004
765 DYSKINESIA 15 0.0004
766 PRODUCT PRESCRIBING ISSUE 8 0.0004
767 DIARRHOEA 237 0.0004
768 CHILLS 43 0.0004
769 CHOLELITHIASIS 12 0.0004
770 BLOOD POTASSIUM DECREASED 11 0.0004
771 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
772 CARDIAC ARREST 30 0.0004
773 VENTRICULAR TACHYCARDIA 6 0.0004
774 FEBRILE NEUTROPENIA 24 0.0004
775 DIVERTICULITIS 10 0.0004
776 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
777 HYPERTENSION 76 0.0004
778 SNEEZING 8 0.0004
779 RESPIRATORY FAILURE 26 0.0004
780 OFF LABEL USE 312 0.0004
781 WEIGHT DECREASED 99 0.0004
782 ABNORMAL BEHAVIOUR 14 0.0004
783 BLOOD PRESSURE ABNORMAL 7 0.0004
784 HYPOPHAGIA 9 0.0004
785 DYSPNOEA 199 0.0004
786 ASTHENIA 132 0.0004
787 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 71 0.0004
788 CARDIOGENIC SHOCK 5 0.0003
789 RASH GENERALISED 9 0.0003
790 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
791 STOMATITIS 21 0.0003
792 HYPERTHYROIDISM 5 0.0003
793 ADVERSE DRUG REACTION 31 0.0003
794 FEEDING DISORDER 7 0.0003
795 ORTHOSTATIC HYPOTENSION 6 0.0003
796 PERIPHERAL SWELLING 53 0.0003
797 BODY TEMPERATURE INCREASED 7 0.0003
798 HEART RATE DECREASED 12 0.0003
799 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
800 COLD SWEAT 6 0.0003
801 ASCITES 10 0.0003
802 CHEST PAIN 63 0.0003
803 PSYCHOTIC DISORDER 10 0.0003
804 PERITONITIS 7 0.0003
805 DISEASE RECURRENCE 16 0.0003
806 THIRST 6 0.0003
807 COLON CANCER 5 0.0003
808 DEVICE ISSUE 30 0.0003
809 HEART RATE INCREASED 33 0.0003
810 GASTROENTERITIS VIRAL 6 0.0003
811 CHEST DISCOMFORT 34 0.0003
812 HYPOAESTHESIA ORAL 5 0.0003
813 COUGH 93 0.0003
814 SWELLING 31 0.0003
815 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
816 NASOPHARYNGITIS 61 0.0003
817 PELVIC PAIN 6 0.0003
818 DEHYDRATION 44 0.0003
819 PLATELET COUNT DECREASED 35 0.0003
820 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
821 FATIGUE 253 0.0003
822 COVID-19 57 0.0003
823 DYSPHONIA 19 0.0003
824 PRURITUS GENERALISED 7 0.0003
825 WHEEZING 19 0.0003
826 MOBILITY DECREASED 23 0.0003
827 PRODUCT USE IN UNAPPROVED INDICATION 79 0.0003
828 BLOOD SODIUM DECREASED 6 0.0003
829 HYPOCALCAEMIA 6 0.0003
830 VOMITING 148 0.0003
831 NAUSEA 248 0.0003
832 LETHARGY 18 0.0003
833 POST PROCEDURAL COMPLICATION 6 0.0003
834 MALAISE 137 0.0003
835 THROAT IRRITATION 14 0.0003
836 POLLAKIURIA 13 0.0003
837 HAEMOGLOBIN DECREASED 32 0.0003
838 ERUCTATION 6 0.0003
839 CHROMATURIA 7 0.0003
840 EXPOSURE VIA SKIN CONTACT 8 0.0003
841 PRODUCT USE ISSUE 58 0.0003
842 HEPATIC ENZYME INCREASED 21 0.0003
843 CEREBRAL HAEMORRHAGE 11 0.0003
844 CONSTIPATION 67 0.0003
845 MUCOSAL INFLAMMATION 8 0.0003
846 SKIN DISCOLOURATION 14 0.0003
847 DERMATITIS ATOPIC 16 0.0003
848 PANCREATITIS 16 0.0003
849 HYPERGLYCAEMIA 11 0.0003
850 DECREASED APPETITE 70 0.0003
851 BLOOD PRESSURE DECREASED 20 0.0003
852 PRESCRIBED UNDERDOSE 6 0.0003
853 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
854 INJURY 21 0.0003
855 CELLULITIS 15 0.0003
856 NEUTROPHIL COUNT DECREASED 12 0.0003
857 FEELING HOT 18 0.0003
858 MOOD ALTERED 8 0.0003
859 FEELING ABNORMAL 70 0.0003
860 PRODUCT PREPARATION ERROR 6 0.0003
861 CONTUSION 28 0.0003
862 JOINT SWELLING 35 0.0003
863 ABNORMAL DREAMS 8 0.0003
864 TOOTH LOSS 6 0.0003
865 NASAL CONGESTION 17 0.0003
866 HYPOTENSION 58 0.0003
867 HAEMOPTYSIS 8 0.0003
868 DIZZINESS 143 0.0003
869 INTENTIONAL PRODUCT MISUSE 25 0.0003
870 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
871 DISCOMFORT 17 0.0003
872 HAEMORRHAGE 29 0.0003
873 DEEP VEIN THROMBOSIS 18 0.0003
874 ABDOMINAL PAIN LOWER 7 0.0003
875 FAECES DISCOLOURED 6 0.0003
876 HAEMATEMESIS 7 0.0003
877 LIVER FUNCTION TEST ABNORMAL 8 0.0003
878 NEEDLE ISSUE 8 0.0003
879 LOSS OF CONSCIOUSNESS 35 0.0003
880 SKIN EXFOLIATION 23 0.0003
881 MULTIPLE SCLEROSIS 13 0.0003
882 UNRESPONSIVE TO STIMULI 7 0.0003
883 LABORATORY TEST ABNORMAL 8 0.0003
884 BLOOD GLUCOSE DECREASED 13 0.0003
885 JOINT STIFFNESS 7 0.0003
886 HOSPITALISATION 41 0.0003
887 IRRITABILITY 16 0.0003
888 PULMONARY EMBOLISM 25 0.0003
889 AMNESIA 17 0.0003
890 PAIN OF SKIN 7 0.0003
891 ASTHMA 29 0.0003
892 ABDOMINAL DISCOMFORT 43 0.0003
893 CHOKING 5 0.0003
894 RECTAL HAEMORRHAGE 11 0.0003
895 INFLUENZA LIKE ILLNESS 21 0.0003
896 BLOOD PRESSURE INCREASED 39 0.0003
897 RESPIRATORY ARREST 7 0.0003
898 DISEASE PROGRESSION 30 0.0003
899 DRUG INEFFECTIVE 333 0.0003
900 FEELING COLD 7 0.0003
901 MIGRAINE 24 0.0003
902 SKIN BURNING SENSATION 18 0.0003
903 WOUND 7 0.0003
904 SYNCOPE 25 0.0002
905 ADVERSE EVENT 23 0.0002
906 DIABETES MELLITUS 19 0.0002
907 HYPERHIDROSIS 32 0.0002
908 SUICIDE ATTEMPT 15 0.0002
909 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
910 FLUSHING 25 0.0002
911 OVERDOSE 53 0.0002
912 URINARY RETENTION 8 0.0002
913 UNEVALUABLE EVENT 18 0.0002
914 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
915 ABDOMINAL PAIN UPPER 47 0.0002
916 COMPLETED SUICIDE 19 0.0002
917 DRUG INTOLERANCE 22 0.0002
918 HOT FLUSH 17 0.0002
919 LIVER DISORDER 10 0.0002
920 DRY SKIN 30 0.0002
921 GLOSSODYNIA 5 0.0002
922 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
923 AGGRESSION 11 0.0002
924 CEREBROVASCULAR ACCIDENT 37 0.0002
925 MOVEMENT DISORDER 7 0.0002
926 WITHDRAWAL SYNDROME 9 0.0002
927 THERAPY CESSATION 11 0.0002
928 ILL-DEFINED DISORDER 13 0.0002
929 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
930 BLOOD PRESSURE FLUCTUATION 5 0.0002
931 TYPE 2 DIABETES MELLITUS 7 0.0002
932 DEVICE DISLOCATION 9 0.0002
933 PSORIASIS 27 0.0002
934 CEREBRAL INFARCTION 5 0.0002
935 GASTRIC DISORDER 7 0.0002
936 SOMNOLENCE 41 0.0002
937 ACUTE MYOCARDIAL INFARCTION 6 0.0002
938 DYSPEPSIA 20 0.0002
939 RHEUMATOID ARTHRITIS 23 0.0002
940 CARDIAC FAILURE CONGESTIVE 16 0.0002
941 THROMBOSIS 16 0.0002
942 CORONARY ARTERY DISEASE 6 0.0002
943 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
944 TOXICITY TO VARIOUS AGENTS 33 0.0002
945 ALOPECIA 38 0.0002
946 DRUG DEPENDENCE 31 0.0002
947 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
948 NERVOUSNESS 10 0.0002
949 WEIGHT INCREASED 41 0.0002
950 OSTEONECROSIS 6 0.0002
951 CARDIAC DISORDER 17 0.0002
952 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
953 FLATULENCE 10 0.0002
954 ABORTION SPONTANEOUS 7 0.0002
955 HYPERSOMNIA 5 0.0002
956 ROAD TRAFFIC ACCIDENT 7 0.0002
957 INCORRECT DOSE ADMINISTERED 38 0.0002
958 DRUG EFFECT INCOMPLETE 6 0.0002
959 ABDOMINAL DISTENSION 17 0.0002
960 DRY MOUTH 13 0.0002
961 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
962 UNDERDOSE 11 0.0002
963 PRODUCT STORAGE ERROR 13 0.0001
964 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
965 DEATH 127 0.0001
966 INFUSION RELATED REACTION 9 0.0001
967 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
968 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
969 ACNE 10 0.0001
970 SKIN IRRITATION 6 0.0001
971 EXPOSURE DURING PREGNANCY 8 0.0001
972 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
973 HAEMATOCHEZIA 7 0.0001
974 INTENTIONAL OVERDOSE 8 0.0001
975 DEVICE BREAKAGE 5 0.0001
976 MYOCARDIAL INFARCTION 21 0.0001
977 BLOOD CHOLESTEROL INCREASED 5 0.0001
978 NEOPLASM MALIGNANT 7 0.0001
979 INJECTION SITE ERYTHEMA 12 0.0001
980 PRODUCT QUALITY ISSUE 13 0.0001
981 DRUG EFFECT DECREASED 5 0.0001
982 INJECTION SITE PAIN 27 0.0001
983 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
984 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
985 BLOOD GLUCOSE INCREASED 15 0.0001
986 DRUG DOSE OMISSION 13 0.0001
987 INJECTION SITE SWELLING 6 0.0001
988 INJECTION SITE HAEMORRHAGE 6 0.0001
989 INJECTION SITE BRUISING 5 0.0001
990 BREAST CANCER 5 0.0001